Eric Karas

Business address
C/O Ars Pharmaceuticals, Inc., 11682 El Camino Real, Suite 120, San Diego, CA, 92130
Top holdings (ownership)
SPRY
Get insider transactions for this reporting owner
Eric Karas has filed 18 SEC EDGAR filings since 10 Nov 2022

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing 03 Jul 2025 01 Jul 2025 001-39756
144 Open Document Open Filing 01 Jul 2025
4 Open Document Open Filing 20 Jun 2025 18 Jun 2025 001-39756
144 Open Document Open Filing 18 Jun 2025
4 Open Document Open Filing 21 Mar 2025 20 Mar 2025 001-39756
144 Open Document Open Filing 20 Mar 2025
4 Open Document Open Filing 03 Jan 2025 02 Jan 2025 001-39756
4 Open Document Open Filing 04 Dec 2024 02 Dec 2024 001-39756
144 Open Document Open Filing 04 Dec 2024
144 Open Document Open Filing 02 Dec 2024
4 Open Document Open Filing 19 Sep 2024 18 Sep 2024 001-39756
144 Open Document Open Filing 18 Sep 2024
4 Open Document Open Filing 21 Aug 2024 19 Aug 2024 001-39756
144 Open Document Open Filing 19 Aug 2024
4 Open Document Open Filing FORM 4 SUBMISSION 04 Jan 2024 02 Jan 2024 001-39756
4 Open Document Open Filing FORM 4 SUBMISSION 05 Jan 2023 03 Jan 2023 001-39756
4 Open Document Open Filing FORM 4 SUBMISSION 10 Nov 2022 08 Nov 2022 001-39756
3 Open Document Open Filing FORM 3 SUBMISSION 10 Nov 2022 08 Nov 2022 001-39756